Preoperative Partitioning of Pulmonary Vascular Resistance Correlates With Early Outcome After Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension

Background—Pulmonary thromboendarterectomy (PTE) is the preferred treatment for chronic thromboembolic pulmonary hypertension (CTEPH), but persistent pulmonary hypertension after PTE, as a result of either inaccessible distal thrombotic material or coexistent intrinsic small-vessel disease, remains a major determinant of poor outcome. Conventional preoperative evaluation is unreliable in identifying patients at risk for persistent pulmonary hypertension or predicting postoperative hemodynamic outcome. We postulated that pulmonary arterial occlusion pressure waveform analysis, a technique that has been used for partitioning pulmonary vascular resistance, might identify CTEPH patients with significant distal, small-vessel disease. Methods and Results—Twenty-six patients underwent preoperative right heart catheterization before PTE. Pulmonary artery occlusion waveform recordings were performed in triplicate. Postoperative hemodynamics after PTE were compared with preoperative partitioning of pulmonary vascular resistance derived from the occlusion data. Preoperative assessment of upstream resistance (R up) correlated with both postoperative total pulmonary resistance index (R2=0.79, P <0.001) and postoperative mean pulmonary artery pressure (R2=0.75, P <0.001). All 4 postoperative deaths occurred in patients with a preoperative R up <60%. Conclusions—Pulmonary arterial occlusion pressure waveform analysis may identify CTEPH patients at risk for persistent pulmonary hypertension and poor outcome after PTE. Patients with CTEPH and R up value <60% appear to be at highest risk.

[1]  K. Kerr,et al.  Long-term outcome after pulmonary thromboendarterectomy. , 1999, American journal of respiratory and critical care medicine.

[2]  K. Moser,et al.  Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. , 1993, Chest.

[3]  R. Naeije,et al.  Single arterial occlusion to locate resistance in patients with pulmonary hypertension , 2003, European Respiratory Journal.

[4]  W. Seeger,et al.  Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. , 2003, American journal of respiratory and critical care medicine.

[5]  P. Baconnier,et al.  Theoretical analysis of occlusion techniques for measuring pulmonary capillary pressure. , 1992, Journal of applied physiology.

[6]  M. Ando,et al.  Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. , 2003, Chest.

[7]  P. Thistlethwaite,et al.  Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. , 2002, The Journal of thoracic and cardiovascular surgery.

[8]  H. Schäfers,et al.  Pulmonary thromboendarterectomy--risk factors for early survival and hemodynamic improvement. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  M. Levitzky,et al.  A comparison of pulmonary arterial occlusion algorithms for estimation of pulmonary capillary pressure. , 1999, American journal of respiratory and critical care medicine.

[10]  R. Michel,et al.  Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[11]  C. Mélot,et al.  Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. , 1998, Journal of the American College of Cardiology.

[12]  W. Seeger,et al.  Inhaled iloprost for severe pulmonary hypertension. , 2002, The New England journal of medicine.

[13]  M. Uematsu,et al.  Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension , 2002, Heart.

[14]  T. Hakim,et al.  Occlusion pressures vs. micropipette pressures in the pulmonary circulation. , 1989, Journal of applied physiology.

[15]  S. Rich,et al.  Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series , 1999, Annals of Internal Medicine.

[16]  R. Naeije,et al.  Continuous versus pulsatile pulmonary hemodynamics in canine oleic acid lung injury. , 2000, American journal of respiratory and critical care medicine.